Cargando…
A predictive model of polymetastatic disease from a multicenter large retrospectIve database on colorectal lung metastases treated with stereotactic ablative radiotherapy: The RED LaIT-SABR study
AIM: Stereotactic ablative radiotherapy (SABR) showed increasing survival in oligometastatic patients. Few studies actually depicted oligometastatic disease (OMD) evolution and which patient will remain disease-free and which will rapidly develop a polymetastatic disease (PMD) after SABR. Therefore,...
Ejemplares similares
-
Study protocol: PreOperative Brain Irradiation in Glioblastoma (POBIG) – A phase I trial
por: Waqar, Mueez, et al.
Publicado: (2023) -
Stereotactic magnetic resonance-guided online adaptive radiotherapy of adrenal metastases combines high ablative doses with optimized sparing of organs at risk
por: Hoegen, Philipp, et al.
Publicado: (2022) -
Prognostic impact of biologically equivalent dose in stereotactic body radiotherapy for renal cancer
por: Tran, Kevin T., et al.
Publicado: (2023) -
Circulating neutrophils and tumor-associated myeloid cells function as a powerful biomarker for response to chemoradiation in locally advanced cervical cancer
por: Gjyshi, Olsi, et al.
Publicado: (2023) -
DNA-methylation and genomic copy number in primary tumors and corresponding lymph node metastases in prostate cancer from patients with low and high Gleason score
por: Unger, Kristian, et al.
Publicado: (2023)